Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Scilex Holding (SCLXW) Research & Development (2022 - 2025)

Scilex Holding has reported Research & Development over the past 4 years, most recently at $3.9 million for Q3 2025.

  • Quarterly results put Research & Development at $3.9 million for Q3 2025, up 65.99% from a year ago — trailing twelve months through Sep 2025 was $14.7 million (up 44.4% YoY), and the annual figure for FY2024 was $9.6 million, down 24.36%.
  • Research & Development for Q3 2025 was $3.9 million at Scilex Holding, down from $6.2 million in the prior quarter.
  • Over the last five years, Research & Development for SCLXW hit a ceiling of $6.2 million in Q2 2025 and a floor of $1.2 million in Q3 2022.
  • Median Research & Development over the past 4 years was $2.6 million (2022), compared with a mean of $2.9 million.
  • Biggest five-year swings in Research & Development: soared 229.18% in 2023 and later crashed 42.31% in 2024.
  • Scilex Holding's Research & Development stood at $2.6 million in 2022, then increased by 5.28% to $2.7 million in 2023, then decreased by 20.26% to $2.2 million in 2024, then skyrocketed by 78.85% to $3.9 million in 2025.
  • The last three reported values for Research & Development were $3.9 million (Q3 2025), $6.2 million (Q2 2025), and $2.5 million (Q1 2025) per Business Quant data.